Corrigendum to "IFI16 promotes cervical cancer progression by upregulating PD-L1 in immunomicroenvironment through STING-TBK1-NF-kB pathway" [Biomed. Pharmacother. 123 (2020) 109790].

Cai, Hongning; Yan, Lin; Liu, Nian; Xu, Meng; Cai, Hongbing

Cai, Hongning; Yan, Lin; Liu, Nian; Xu, Meng; Cai, Hongbing.

Afiliação

Cai H; The Second Clinical College, School of Medicine, Wuhan University, Wuhan, 430071, China; Department of Gynecologic Oncology, Maternal and Child Health Hospital of Hubei Province, Wuhan, 430071, China; Women and Children's Hospital of Hubei Province, NO. 745 Wu LuoRoad, Hongshan District, Wuhan, Hube
Yan L; Department of Obstetrics and Gynecology, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430010, China.
Liu N; Department of Women Health Care, Department of Gynecologic Oncology, Maternal and Child Health Hospital of Hubei Province, Women and Children's Hospital of Hubei Province, NO. 745 Wuluo Road, Hongshan District, Wuhan, Hubei Province, China.
Xu M; Medical Research Institute, Wuhan University, Wuhan, 430071, China.
Cai H; Department of Gynecologic Oncology, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China. Electronic address: Caihongbing2105@gmail.com.

Biomed Pharmacother ; 126: 110077, 2020 06.

Article em En | MEDLINE | ID: mdl-32173085

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2020 Tipo de documento: Article